StockNews.com started coverage on shares of Calithera Biosciences (NASDAQ:CALA – Free Report) in a research report released on Sunday. The firm issued a hold rating on the biotechnology company’s stock.
Calithera Biosciences Stock Performance
Shares of NASDAQ CALA opened at $0.00 on Friday. Calithera Biosciences has a fifty-two week low of $0.00 and a fifty-two week high of $0.12.
Calithera Biosciences Company Profile
Further Reading
- Five stocks we like better than Calithera Biosciences
- What Investors Need to Know to Beat the Market
- How to Build the Ultimate Everything ETF Portfolio
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- Earnings Per Share Calculator: How to Calculate EPS
- 3 Stocks With High ROE and Market-Beating Growth Potential
Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
